Industry Dive, a Washington, D.C.-based business journalism outlet, is acquiring PharmaVOICE, a trade publication for pharmaceutical industry executives, for an undisclosed amount, reports Sara Fischer of Axios.
Fischer reports, “The company, which is expected to finish 2021 with more than $80 million in revenue, is pursuing a similar strategy to several other media companies that are trying to remain independent: acquire small brands to get bigger incrementally.
“Details: PharmaVOICE is a hyper-niche publication read by roughly 60,000 pharmaceutical executives. The company, which also produces events and podcasts, will remain a standalone brand under Industry Dive.
“This is IndustryDive’s fourth deal. In June 2020 it acquired a content marketing studio from NewsCred, a global technology company, which it combined with its own content studio and relaunched as studioID.”
Read more here.
